Last updated: April 11, 2023
Sponsor: University Hospital, Saarland
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pain (Pediatric)
Treatment
N/AClinical Study ID
NCT03773003
IMPROFA
Ages 18-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- histologically, cytologically or radiologically confirmed tumor disease
- indication for chemotherapy
- Written consent to participation
Exclusion
Exclusion Criteria:
- chronic-inflammatory bowel disease
- pregnancy
Study Design
Total Participants: 150
Study Start date:
July 20, 2021
Estimated Completion Date:
December 01, 2024
Study Description
Connect with a study center
Saarland University Medical Center
Homburg, Saarland 66424
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.